Abstract
Glycal assembly offers an expedient entry into β-linked oligosaccharides, but epoxyglycal donors can be capricious in their reactivities. Treatment with Et2NH and CS2 enables their in situ conversion into glycosyl dithiocarbamates, which can be activated by copper triflate for coupling with complex or sterically congested acceptors. The coupling efficiency can be further enhanced by in situ benzoylation, as illustrated in an 11-step synthesis of a branched hexasaccharide from glucals in 28% isolated yield and just 4 chromatographic purifications.
General strategies for efficient and stereoselective glycosyl couplings continue to provide a challenge for synthetic method development, despite the many mechanistic insights and technological advances in glycosyl bond formation.1,2,3 In 1989, Halcomb and Danishefsky introduced an approach for the expedient synthesis of β-linked oligosaccharides, based on the stereoselective epoxidation of glycals followed by coupling with glycal acceptors under mild Lewis acid conditions.4,5 The “glycal assembly” strategy differs significantly from conventional methods of carbohydrate synthesis: the intermediate epoxyglycal donors can be used without workup or purification, and the C2 substituent of the glycosylation products can be modified at a later stage, permitting greater flexibility in synthetic design. Glycals and their epoxides have also proven amenable to solid-phase oligosaccharide synthesis.6
Despite its potential advantages, the efficiency of glycal assembly has been limited by the variable reactivity of the epoxyglycal donors, as well as by the range of acceptors that can serve as nucleophiles. For instance, tri-O-benzyl α-epoxyglucal is highly sensitive even to mild Lewis acids, and its use as a glycosyl donor has produced moderate yields at best.5,7,8,9,13 Efforts to improve coupling yields by optimizing the Lewis acid catalyst or by increasing the nucleophilicity of the acceptor have met with mixed success.10,11,12 Epoxyglycals can be converted into standard glycosyl donors for activation by stronger Lewis acid catalysts, but this requires additional steps to isolate and purify the synthetic intermediates.13,14,15 Furthermore, the use of strong Lewis acids is incompatible with glycal acceptors, which defeats a primary merit of the glycal assembly method.
Here we describe coupling conditions that bring the glycal assembly strategy to its full potential. They are based on the one-pot conversion of epoxyglycals into glycosyl dithiocarbamates (DTCs), by treatment with diethylamine and CS2, and the selective activation of the glycosyl DTCs with Cu(I) or Cu(II) triflate to initiate glycosyl coupling (Figure 1). This procedure is both highly β-selective and compatible with glycals and other sensitive glycosyl acceptors, and does not require purification of the glycosyl DTC intermediate.
Figure 1.
The glycal assembly approach to β-linked glycosides, aided by the in situ generation of a glycosyl dithiocarbamate prior to glycosyl coupling and chromatographic purification.
The coupling reaction proceeds with a free C2 hydroxyl on the glycosyl donor, but can be enhanced further by in situ 2-O-acylation for the expeditious assembly of complex β-linked oligosaccharides. We demonstrate this with the concise synthesis of a branched hexasaccharide from the β-glucan family, whose members have strong immunomodulatory potential but whose structure–activity relationships have not been fully addressed, due to limited availability of well-characterized structures.16,17
Glycosyl DTCs have been underutilized as donors compared to glycosyl sulfides or thioimidates.1,18,19,20 However, the reduction potentials of DTCs are less than that of thiols (E0(Et2NCS2–/thiuram disulfide) = –302 mV, versus E0(PhS–/PhSSPh) = –541 mV),21 indicating facile ionization and mild activation conditions for glycosyl coupling.22 Furthermore, DTCs can be prepared by the simple condensation of amines with CS2 in polar solvents,23,24 and are excellent nucleophiles for epoxide ring-opening. These features suggested to us that glycosyl DTCs could be ideal surrogates for glycal assembly.
The conversion of tri-O-benzyl glucal 1 into a glycosyl N,N-diethyldithiocarbamate (Et2DTC) was achieved in situ, by stereoselective DMDO oxidation followed by treatment with Et2NH and CS2 (pre-mixed to form the Et2DTC diethylammonium salt) to yield the desired glycosyl DTC with >95% β selectivity.25 A survey of Lewis acids revealed that glycosyl DTCs were readily activated by CuII(OTf)2 or CuIOTf·(C6H6)0.5 at low temperatures, using 2,4,6-(tBu)3-pyrimidine (TTBP) as an acid scavenger. We were pleased to find that Cu(OTf)x activation could be performed using unpurified glycosyl DTCs, and was also compatible with both acid- and base-sensitive functional groups, allowing glycal donors to be coupled efficiently with a variety of acceptors without intermediate workup.
One-pot glycal couplings were performed using 1 or Glcβ(1→6)glucal 2 as donors and 1.2–1.5 equiv of acceptors to produce β-glycosides 3–9 in good yields and selectivities (Table 1). The stereochemistry of all products or their 2-O-acetates was confirmed by 1H NMR coupling constant or pulsed-field gradient (pfg) COSY analysis (see Supporting Information).
Table 1.
One-pot glycal coupling via in situ glycosyl dithiocarbamate (DTC) formation.
|
a Standard conditions: (i) DMDO (1.5 equiv), 0 °C, CH2Cl2; (ii) CS2 (1.05 equiv), Et2NH (2.1 equiv), MeOH, rt; (iii) [Donor] = 0.15 M; Cu(OTf)x, TTBP (2 equiv each), 4 Å mol sieves, –50 °C, 1:1 CH2Cl2: C2H4Cl2, then acceptor (1.5 equiv); reaction quenched at 10 °C. A: Cu(OTf)2; B: CuOTf. b Isolated yields of β isomer, unless stated otherwise. c Yields in parentheses (reported in references 4–7) are shown for comparison. d 1.3 equiv acceptor. e Reaction quenched at –30 °C. f Obtained as a 9:1 β:α mixture. g DMDO, –55 °C. h [Donor] = 0.2 M; 1.2 equiv acceptor. i Also isolated α isomer (7%).
It is worth noting that the C2 hydroxyl of the intermediate DTC glycoside does not interfere with glycosyl coupling, as no side products corresponding to self-coupling or oligomerization could be identified. Instead, the C2 hydroxyl likely plays an active role in promoting β-glycosylation by generating a tetrahedral intermediate that hinders nucleophiles from approaching the α face (Figure 2). Complementary studies on the reactivity of glycosyl DTCs support this argument, and will be reported elsewhere.26
Figure 2.
Cu-mediated activation of the glycosyl DTC intermediate (L = coordination ligand). The participation of the C2 hydroxyl promotes the formation of β-glycosides.
While the scope of glycal assembly is substantially improved by the in situ generation of glycosyl DTCs (Table 1), this, alone, is not enough for the efficient coupling of glycal donors and acceptors into larger oligosaccharides, which is an important objective for its continued development.5,6 For instance, some 1,3- and 1,4-linked disaccharides could only be obtained in fair yields (Table 2, footnote d). We recognized that a 2-O-benzoate (Bz) would be useful to enhance donor reactivity, as has been demonstrated with glycosyl thioimidates.20,27 We thus developed a chromatography-free method for preparing 2-O-Bz glycosides that would retain the processing advantages of glycal assembly. In situ conversion of glycal donors 1, 10, and 11 into their corresponding 2-O-Bz glycosyl DTCs proved to be facile and also compatible with CuOTf or Cu(OTf)2-mediated glycosylation directly after workup. This allowed compounds 12–17 to be produced in high yields and with exclusive β selectivity (Table 2).
Table 2.
Oligosaccharide assembly via in situ benzoylation of glycosyl DTC intermediates.
|
a Standard conditions: (i) DMDO (1.5 equiv), 0 °C, CH2Cl2; (ii) CS2 (1.05 equiv), Et2NH (2.1 equiv), MeOH, rt; (iii) BzCl (4 equiv, 0.4 M), pyridine, rt; (iv) [Donor] = 0.15 M; Cu(OTf)x, TTBP (2 equiv each), 4 Å mol sieves, –50 °C, 1:1 CH2Cl2:C2H4Cl2; acceptor added at –50 °C; reaction quenched at 10 °C. A: Cu(OTf)2 and 1.5 equiv acceptor; B: CuOTf and 1.5 equiv acceptor; C: CuOTf and 1.4 equiv donor. b Isolated yields of β isomer, unless stated otherwise. c Also isolated 1,2-orthobenzoate byproduct (6%). d Yields in parentheses for glycosyl couplings without in situ 2-O-benzoylation, shown for comparison. e 1.3 equiv acceptor. f DMDO (1.5 equiv), –55 °C. g Glycosyl coupling without in situ 2-O-benzoylation produces a 5:1 β:α mixture.
Benzoylation of the intermediate DTC glycoside was particularly beneficial in couplings involving less reactive glycal donors such as conformationally locked glucal 11, with an increase in overall yields by more than 30%. Such modifications effectively remove any limitations previously associated with the efficiency of glycal assembly, including the formation of β-1,2-, β-1,3-, and β-1,4-linked oligosaccharides.13,28
The modified glycal assembly conditions can be applied to a variety of naturally-occurring β-linked oligosaccharides and glycoconjugates. For example, glycal 15 is a precursor for the branched tetrasaccharide of a pregnane glycoside (Glcβ(1→6)[Glcβ(1→2)]Glcβ(1→6)Glcβ-) isolated from Stelmatocrypton khasianum.29 To determine whether modified glycal assembly could provide an efficient entry into sterically congested glycans, we designed a synthetic route toward oligomers of [Glcβ(1→3)[Glcβ-(1→2)]Glcβ(1→3)]n-, a trisaccharide repeat unit of a branched β-glucan produced by probiotic strains of the Pediococcus genus.30 The diverse biological activities of branched β-glucans have gained prominence in recent years, and include a broad range of human health benefits16,17,31 as well as regulatory functions in plants32 and bacterial biofilm formation.33,34 The crowded 1,2;1,3-linkage provides a stringent test for glycosyl coupling, as the steric congestion around the branched acceptor impedes both coupling efficiency and stereoselectivity.35
The p-methoxybenzyl (PMB)-protected glucal donor 18 was coupled with glucal acceptor 19 using a slight variation of the previous reaction conditions. Epoxidation was performed at –30 °C using a modest excess of DMDO, followed by treatment with 1.3 equivalents of Et2DTC in MeOH (Scheme 1). In this case, the DTC salt also served as a DMDO scavenger to prevent over-oxidation of the 3-O-PMB ether. The crude glycosyl DTC intermediate was benzoylated as previously described, then subjected to CuOTf-mediated coupling with 1.5 equivalents of 19 to produce disaccharide glycal 20 in 71% overall yield from 18 after chromatography.
Scheme 1.
Synthesis of a branched β-glucan by modified glycal assembly
The 2′-O-Bz ester was saponified and then subjected to a one-pot coupling with two equivalents of donor 1 using our modified glycal assembly conditions, to produce branched trisaccharide glycal 14 in 92% yield from 20.36 Acceptor 21 (1.2 equiv) was prepared from donor 14 by oxidative cleavage of the 3'-O-PMB ether in 90% yield, then coupled under previously optimized conditions to produce 22 in 47% isolated yield (Scheme 1). The synthesis of hexasaccharide glycal 22 from glucals 18 and 19 was achieved in 11 steps and with only 4 chromatographic purifications, in an overall yield of 28%. Furthermore, 22 was produced as a single diastereomer despite the creation of 10 stereocenters. In this regard, the DMDO epoxidation of disaccharide glycal 20, trisaccharide glycal 14 and hexasaccharide glycal 22 all furnished β-glycosyl DTCs with over 95% stereoselectivity, irrespective of their size.25
Remarkably, the internal β-glucoside at the newly formed 1,3-linkage (ring D) of hexasaccharide 22 was significantly distorted from a chair (4C1) conformation (J1,2 = 5.3 Hz), despite the torsional constraints imposed by the 4,6-benzylidene acetal. Additional NMR analysis of ring D suggested a twist-boat conformation, which may serve to alleviate steric interactions with neighboring residues on ring B (see Supporting Information). This is in accord with earlier reports of anomalously low J1,2 values for one or more pyranosides in protected derivatives of 1,3-linked β-glucans.37 The β configuration of ring D was eventually confirmed by 13C NMR analysis of its anomeric carbon (δ(C1D) 99.8 ppm; 1JCH = 166.1 Hz),38 and also by key dipolar couplings between rings B and D via 2D-ROESY analysis.
It is worth mentioning that hexasaccharide glycal 22 could also be oxidized into an epoxyglycal with DMDO, and coupled with trisaccharide acceptor 21 using modified glycal assembly conditions (see Supporting Information for partial characterization). However, the expected nonasaccharide glycal could not be isolated by chromatographic separation, possibly due to the sensitivity of the strained β-1,3-linkages.
In conclusion, glycal assembly via the in situ generation of 2-O-Bz glycosyl DTCs is competitive with standard methods of preparing β-linked oligosaccharides, while reducing the burden of isolating and purifying synthetic intermediates. Glycal donors can be coupled with sterically congested acceptors under mild conditions to enable the expedient assembly of complex β-glucans, including those whose internal linkages exhibit considerable torsional strain.
Supplementary Material
Acknowledgment
We gratefully acknowledge financial support from the National Institutes of Health (GM-06982), the National Science Foundation (CHE-0957738), and a predoctoral scholarship from the Royal Thai government for P.P. We also acknowledge NMR and MS support from the Purdue University Center for Cancer Research, and thank Dr. John Harwood of the Purdue Interdepartmental NMR facility for assistance with 2D NMR experiments.
Footnotes
Supporting Information Available. Complete experimental details and NMR spectra of enumerated compounds. This material is available free of charge via the Internet at http://pubs.acs.org.
References
- 1.Smoot JT, Demchenko AV. Adv. Carbohydr. Chem. Biochem. 2009;62:161. doi: 10.1016/S0065-2318(09)00005-5. [DOI] [PubMed] [Google Scholar]
- 2.Boltje TJ, Buskas T, Boons G-J. Nat. Chem. 2009;1:611. doi: 10.1038/nchem.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Boltje TJ, Kim J-H, Park J, Boons G-J. Nat. Chem. 2010;2:552–557. doi: 10.1038/nchem.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Halcomb RL, Danishefsky SJ. J. Am. Chem. Soc. 1989;111:6661. [Google Scholar]
- 5.Seeberger PH, Bilodeau MT, Danishefsky SJ. Aldrichimica Acta. 1997;30:75. [Google Scholar]
- 6.Danishefsky SJ, McClure KF, Randolph JT, Ruggeri RB. Science. 1993;260:1307. doi: 10.1126/science.8493573. [DOI] [PubMed] [Google Scholar]
- 7.Gervay J, Danishefsky SJ. J. Org. Chem. 1991;56:5448. [Google Scholar]
- 8.Timmers CM, van der Marel GA, van Boom JH. Chem. Eur. J. 1995;1:161. [Google Scholar]
- 9.Fortin M, Kaplan JP, K., Kirk S, Andrade RB. Org. Lett. 2009;11:3594. doi: 10.1021/ol901313z. [DOI] [PubMed] [Google Scholar]
- 10.Li Y, Tang P, Chen Y, Yu B. J. Org. Chem. 2008;73:4323. doi: 10.1021/jo8003875. [DOI] [PubMed] [Google Scholar]
- 11.Liu KKC, Danishefsky SJ. J. Am. Chem. Soc. 1993;115:4933. [Google Scholar]
- 12.Randolph JT, Danishefsky SJ. J. Am. Chem. Soc. 1993;115:8473. [Google Scholar]
- 13.a Seeberger PH, Eckhardt M, Gutteridge CE, Danishefsky SJ. J. Am. Chem. Soc. 1997;119:10064. [Google Scholar]; b Zheng C, Seeberger PH, Danishefsky SJ. J. Org. Chem. 1998;63:1126. [Google Scholar]
- 14.Plante OJ, Andrade RB, Seeberger PH. Org. Lett. 1999;1:211. doi: 10.1021/ol9905452. [DOI] [PubMed] [Google Scholar]
- 15.Plante OJ, Palmacci ER, Andrade RB, Seeberger PH. J. Am. Chem. Soc. 2001;123:9545. doi: 10.1021/ja016227r. [DOI] [PubMed] [Google Scholar]
- 16.Fernández de Palencia P, Werning ML, Sierra-Filardi E, Dueñas MT, Irastorza A, Corbí AL, López P. Appl. Environ. Microbiol. 2009;75:4887. doi: 10.1128/AEM.00394-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Chan G, Chan W, Sze D. J. Hematol. Oncol. 2009;2:25. doi: 10.1186/1756-8722-2-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bogusiak J, Szeja W. Carbohydr. Res. 1996;295:235. doi: 10.1016/s0008-6215(00)00220-2. [DOI] [PubMed] [Google Scholar]
- 19.Fügedi P, Garegg PJ, Oscarson S, Rosén G, Silwanis BA. Carbohydr. Res. 1991;211:157. [Google Scholar]
- 20.Mydock LK, Demchenko AV. Org. Lett. 2008;10:2103. doi: 10.1021/ol800345j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nichols PJ, Grant MW. Aust. J. Chem. 1982;35:2455. [Google Scholar]
- 22.Yamago S, Kokubo K, Hara O, Masuda S, Yoshida J.-i. J. Org. Chem. 2002;67:8584. doi: 10.1021/jo0261350. [DOI] [PubMed] [Google Scholar]
- 23.Zhao Y, Pérez-Segarra W, Shi Q, Wei A. J. Am. Chem. Soc. 2005;127:7328. doi: 10.1021/ja050432f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhu H, Coleman DM, Dehen CJ, Geisler IM, Zemlyanov D, Chmielewski J, Simpson GJ, Wei A. Langmuir. 2008;24:8660. doi: 10.1021/la801254b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.We note that while the DMDO oxidation of the glucal provides the α-epoxyglycal with 90% facioselectivity (Ref. 4), epoxide ring opening provides additional kinetic resolution to produce glycosyl DTCs with >95% β selectivity. See: Alberch L, Cheng G, Seo S-K, Li X, Boulineau FP, Wei A. J. Org. Chem. 2011;76:2532. doi: 10.1021/jo102382r.
- 26.Padungros P, Alberch L, Wei A. manuscript in preparation.
- 27.Crich D, Li M. Org. Lett. 2007;9:4115. doi: 10.1021/ol701466u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Di Bussolo V, Kim YJ, Gin DY. J. Am. Chem. Soc. 1998;120:13515. [Google Scholar]
- 29.Zhang Q, Zhao Y, Wang B, Feng R, Liu X, Cheng T. Steroids. 2002;67:347. doi: 10.1016/s0039-128x(01)00187-8. [DOI] [PubMed] [Google Scholar]
- 30.a Dueñas-Chasco MT, Rodríguez-Carvajal MA, Mateo PT, Franco-Rodríguez G, Espartero JL, Irastorza-Iribas A, Gil-Serrano AM. Carbohydr. Res. 1997;303:453. doi: 10.1016/s0008-6215(97)00192-4. [DOI] [PubMed] [Google Scholar]; b Velasco SE, Areizaga J, Irastorza A, Dueñas MT, Santamaria A, Muñoz ME. J. Agric. Food Chem. 2009;57:1827. doi: 10.1021/jf803065w. [DOI] [PubMed] [Google Scholar]
- 31.Barsanti L, Passarelli V, Evangelista V, Frassanito AM, Gualtieri P. Nat. Prod. Rep. 2011;28:457. doi: 10.1039/c0np00018c. [DOI] [PubMed] [Google Scholar]
- 32.Albersheim P, Darvill A, Augur C, Cheong J-J, Eberhard S, Hahn MG, Marfa V, Mohnen D, O'Neill MA, Spiro MD, York WS. Acc. Chem. Res. 1992;25:77. [Google Scholar]
- 33.Miller K, Kennedy E, Reinhold V. Science. 1986;231:48. doi: 10.1126/science.3941890. [DOI] [PubMed] [Google Scholar]
- 34.Lequette Y, Rollet E, Delangle A, Greenberg EP, Bohin JP. Microbiology. 2007;153:3255. doi: 10.1099/mic.0.2007/008953-0. [DOI] [PubMed] [Google Scholar]
- 35.a Descroix K, Ferrieres VJ, F., Yvin J-C, Plusquellec D. Mini-Rev. Med. Chem. 2006;6:1341. doi: 10.2174/138955706778993058. [DOI] [PubMed] [Google Scholar]; b Zeng Y, Ning J, Kong F. Tetrahedron Lett. 2002;43:3729. [Google Scholar]; c Zeng Y, Ning J, Kong F. Carbohydr. Res. 2003;338:307. doi: 10.1016/s0008-6215(02)00455-x. [DOI] [PubMed] [Google Scholar]
- 36.We note that glycal coupling with donor as the limiting agent is also high-yielding (Table 2, entry 3) and permits recovery of excess acceptor, but limiting the acceptor is more practical in this case due to ease of purification.
- 37.a Collins PM, Ali MH. Tetrahedron Lett. 1990;31:4517. [Google Scholar]; b Jamois F, Ferrières V, Guégan J-P, Yvin J-C, Plusquellec D, Vetvicka V. Glycobiology. 2005;15:393. doi: 10.1093/glycob/cwi020. [DOI] [PubMed] [Google Scholar]; c Mo KF, Li HQ, Mague JT, Ensley HE. Carbohydr. Res. 2009;344:439. doi: 10.1016/j.carres.2008.12.014. [DOI] [PubMed] [Google Scholar]; d Tanaka H, Kawai T, Adachi Y, Ohno N, Takahashi T. Chem. Commun. 2010;46:8249. doi: 10.1039/c0cc03153d. [DOI] [PubMed] [Google Scholar]
- 38.Bock K, Pedersen C, R. Adv. Carbohydr. Chem. Biochem. 1983;41:27. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




